How to manage mantle cell lymphoma

@article{Dreyling2014HowTM,
  title={How to manage mantle cell lymphoma},
  author={Martin Dreyling and Simone Ferrero and Olivier Hermine},
  journal={Leukemia},
  year={2014},
  volume={28},
  pages={2117-2130}
}
Mantle cell lymphoma (MCL) is no longer a hopeless disease. Considered to carry a uniformly dismal prognosis so far, during the last years it has been rediscovered as a heterogeneous clinical and biological entity. Such a complexity has been highlighted by molecular genetics, unraveling different pathways of cell survival and progression. Concurrently, the application of new therapeutic paradigms including rituximab, high-dose cytarabine and stem cell transplantation dramatically improved… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 23 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 129 REFERENCES

Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.

Mehdi Hamadani, Wael Saber, +19 authors Hillard M. Lazarus
  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2013

Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC

Cyrille Touzeau, C. Leux, +20 authors Steven Le Gouill
  • Annals of Hematology
  • 2013